JP2021527671A5 - - Google Patents
Info
- Publication number
- JP2021527671A5 JP2021527671A5 JP2020570747A JP2020570747A JP2021527671A5 JP 2021527671 A5 JP2021527671 A5 JP 2021527671A5 JP 2020570747 A JP2020570747 A JP 2020570747A JP 2020570747 A JP2020570747 A JP 2020570747A JP 2021527671 A5 JP2021527671 A5 JP 2021527671A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- amino acid
- composition
- dipeptide
- tripeptide
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687727P | 2018-06-20 | 2018-06-20 | |
| US62/687,727 | 2018-06-20 | ||
| US201962794134P | 2019-01-18 | 2019-01-18 | |
| US62/794,134 | 2019-01-18 | ||
| PCT/US2019/038037 WO2019246299A1 (en) | 2018-06-20 | 2019-06-19 | Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527671A JP2021527671A (ja) | 2021-10-14 |
| JP2021527671A5 true JP2021527671A5 (https=) | 2022-09-08 |
| JPWO2019246299A5 JPWO2019246299A5 (https=) | 2022-09-08 |
Family
ID=67185732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570747A Pending JP2021527671A (ja) | 2018-06-20 | 2019-06-19 | インスリン抵抗性及び代謝疾患の軽減又は治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20210275479A1 (https=) |
| EP (1) | EP3810122A1 (https=) |
| JP (1) | JP2021527671A (https=) |
| CN (1) | CN112689508A (https=) |
| MA (1) | MA52953A (https=) |
| WO (1) | WO2019246299A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| CN112823018A (zh) | 2018-06-20 | 2021-05-18 | 胺细拉健康公司 | 制备氨基酸组合物的方法 |
| CN111514276B (zh) * | 2020-06-29 | 2021-07-27 | 黑龙江中医药大学 | 短肽Asp-His-Tyr在制备治疗多囊卵巢综合征的药物中的应用 |
| WO2022266480A1 (en) * | 2021-06-17 | 2022-12-22 | Axcella Health Inc. | Methods of predicting liver fat content and uses thereof |
| WO2023009444A1 (en) | 2021-07-26 | 2023-02-02 | Axcella Health Inc. | Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19 |
| EP4643658A1 (en) * | 2024-04-29 | 2025-11-05 | Laboratorios Ern S.A. | Dietary product for hypoproteic diet |
| CN119679774A (zh) * | 2024-11-15 | 2025-03-25 | 北京体育大学 | 预防或治疗代谢性疾病的药物及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20022927A3 (cs) * | 2000-02-01 | 2003-06-18 | Muscletech Research And Development Inc. | Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly |
| US20050176827A1 (en) * | 2002-05-10 | 2005-08-11 | Lee Steve S. | Compositions and methods for glycogen synthesis |
| CN1557301A (zh) * | 2004-01-15 | 2004-12-29 | 高春平 | 降低老年肥胖型糖尿病人血糖和血脂的组合物 |
| US20050233014A1 (en) * | 2004-03-02 | 2005-10-20 | Lee Steve S | Methods for affecting homeostasis and metabolism in a mammalian body |
-
2019
- 2019-06-19 CN CN201980054586.0A patent/CN112689508A/zh active Pending
- 2019-06-19 JP JP2020570747A patent/JP2021527671A/ja active Pending
- 2019-06-19 US US17/254,027 patent/US20210275479A1/en not_active Abandoned
- 2019-06-19 MA MA052953A patent/MA52953A/fr unknown
- 2019-06-19 WO PCT/US2019/038037 patent/WO2019246299A1/en not_active Ceased
- 2019-06-19 EP EP19736883.0A patent/EP3810122A1/en not_active Withdrawn
-
2023
- 2023-07-27 US US18/360,381 patent/US20240238232A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527671A5 (https=) | ||
| JP2020530845A5 (https=) | ||
| JP2020504108A5 (https=) | ||
| JP2020502183A5 (https=) | ||
| JP2021529736A5 (https=) | ||
| Bertrand et al. | Regulation of intestinal protein metabolism by amino acids | |
| TW201919601A (zh) | 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法 | |
| GB1511302A (en) | Pharmaceutical compositions comprising amino acid analogues | |
| US20060247313A1 (en) | Amino acid composition promoting collagen synthesis | |
| CA2177195A1 (en) | Method and composition for treating renal failure | |
| JPWO2019036471A5 (https=) | ||
| RU2008126294A (ru) | Способы лечения потери мышечной массы | |
| JP2021527670A5 (https=) | ||
| JP2009538832A5 (https=) | ||
| CN108721596A (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| FI3746467T3 (fi) | Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö | |
| WO2007043870A1 (en) | Leucine rich composition | |
| JPWO2019246299A5 (https=) | ||
| CN112689508A (zh) | 减少或治疗胰岛素抗性和代谢病状的组合物和方法 | |
| JP2004521123A5 (https=) | ||
| JPH0773479B2 (ja) | 栄養素組成物 | |
| JP2011523626A5 (https=) | ||
| Fijlstra et al. | Continuous Enteral Administration Can Enable Normal Amino Acid Absorption in Rats with Methotrexate-Induced Gastrointestinal Mucositis2 | |
| EP1849466B8 (en) | Infusion fluid for treating anemia in dialysis patients | |
| JP2534139B2 (ja) | 腎不全用経口アミノ酸製剤 |